This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 1120930
Submitted by lobbyist on: March 19, 2020 06:21:25 PM
Accepted by Registrar on: March 20, 2020 06:59:26 AM
Designated Filer Information
| Anastasiou, Peter |
| 2600 Alfred Nobel Boulevard Suite 400 | |
|
Ville Saint-Laurent, QC, H4S 0A9
|
514-844-8515 |
| Canada |
Organization Information
| Lundbeck Canada Inc. |
| Lundbeck Canada Inc. develops, manufactures and sells innovative biopharmaceutical products for the treatment of disorders originating in the central nervous system (CNS). |
| 2600 Alfred Nobel Boulevard Suite 400 | |
|
Ville Saint-Laurent, QC, H4S 0A9
|
514-844-8515 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| H. Lundbeck a/s |
Ottilavej 9
Cophenhagen Valby DK-2500, Denmark |
Phone: 4536301311 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| March 19, 2020 | |
| September 19, 2020 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Interior Health Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Fraser Health Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 | |
| Public Agency | Provincial Health Services Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 | |
| Public Agency | Provincial Health Services Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 | |
| Public Agency | Provincial Health Services Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 | |
| Public Agency | Provincial Health Services Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss policies respecting medicine reimbursement programs, such as BC PharmaCare and BCCA reimbursement policies; and (2) discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 19, 2020 | |
| Public Agency | Provincial Health Services Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Vancouver Coastal Health Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Vancouver Coastal Health Authority | March 19, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
(1) Discuss market access for Lundbeck Canada Inc.'s portfolio of medicines and listing of Lundbeck Canada Inc.'s products for reimbursement purposes.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Fraser Health Authority | March 19, 2020 |